Fexofenadine: Nursing Drug Guide, Fruit Juice Absorption & NCLEX Review
Second-generation H1 blocker for seasonal allergic rhinitis and chronic idiopathic urticaria—but apple, orange, and grapefruit juice can slash absorption, so doses must be given with water only. Verify renal function before 180 mg once daily, separate aluminum/magnesium antacids, and confirm only one antihistamine is active on the MAR and home list.
Prescribing information warns that grapefruit, orange, and apple juice reduce fexofenadine exposure; bioavailability may fall by about 36% compared with water—take tablets with water only. In decreased renal function, start 60 mg once daily; the 180 mg once-daily strength is not for patients with decreased renal function. Do not give within 15 minutes of aluminum/magnesium antacids. Stacking fexofenadine with another antihistamine is a common medication error.
📋 Contents
⚡ Quick facts
💡 Key takeaway
Before every dose: confirm the patient will take fexofenadine with water (not breakfast juice), verify renal dosing if eGFR is low, separate aluminum/magnesium antacids, and ensure only one antihistamine is scheduled. If allergy symptoms persist despite correct dosing, ask whether juice or antacids blocked absorption before escalating therapy.
Brand names and formulations
Fexofenadine hydrochloride is a selective peripheral H1-receptor antagonist (active metabolite of terfenadine) available as tablets, orally disintegrating tablets (ODT), and oral suspension. This guide reflects current U.S. prescribing information for oral products.
- Tablets: Allegra; generic 30 mg, 60 mg, and 180 mg strengths
- Combination products: Allegra-D and other fexofenadine/pseudoephedrine products — not interchangeable with fexofenadine alone
- Related agents: loratadine and cetirizine — different absorption and sedation profiles
- Not interchangeable with: sedating first-generation antihistamines such as diphenhydramine
Indications
Per U.S. fexofenadine hydrochloride tablet prescribing information:
- Seasonal allergic rhinitis: Relief of symptoms in adults and children 6 years and older
- Chronic idiopathic urticaria: Uncomplicated skin manifestations in adults and children 6 years and older
Nurses use fexofenadine for nasal congestion (adjunct), rhinorrhea, pruritus, and hives. It does not replace epinephrine or emergency therapy for anaphylaxis.
How it works
Fexofenadine is a selective H1-receptor antagonist with peripheral activity. Animal and human data suggest minimal CNS penetration relative to first-generation antihistamines; prescribing information notes no sedative or other central nervous system effects were observed in laboratory animals.
Antihistamine effect on histamine skin wheal-and-flare begins by about 1 hour, peaks around 2–3 hours, and persists at 12 hours at labeled doses in pharmacodynamic studies cited in labeling.
Dosing
Oral route only. Take with water. Match strength (30 mg, 60 mg, 180 mg) to the order and product label.
Adults and children 12 years and older (tablets)
| Regimen | Dose |
|---|---|
| Standard | 60 mg twice daily or 180 mg once daily with water |
| Decreased renal function | Start 60 mg once daily; 180 mg once daily is not for use in patients with decreased renal function per labeling |
On a small screen, swipe or scroll sideways to see the full table.
Children 6 to 11 years
Younger pediatric oral suspension
Prescribing information for oral suspension products defines weight-based twice-daily dosing for children 6 months to less than 12 years. Nurses should use the specific product label for the formulation on hand—doses are not interchangeable across liquid and tablet strengths without pharmacy verification.
Pharmacokinetics
- Absorption: Tmax ~2.6 hours after oral tablet; high-fat meal may lower AUC and Cmax modestly
- Fruit juice: Grapefruit, orange, and apple juice reduce bioavailability—population analysis estimated ~36% lower bioavailability versus water
- Half-life: Mean ~14.4 hours after 60 mg twice daily in healthy adults; prolonged in renal impairment
- Elimination: ~80% fecal, ~11% urinary recovery in mass-balance studies; substantially renally eliminated
- Metabolism: Minimal hepatic metabolism (~5%)
Safety check — Before you give
Answer these before the first dose or when reconciling home supply:
- Correct patient, drug, strength (30 mg vs 60 mg vs 180 mg), route (oral), and scheduled time
- Patient will take dose with water—not apple, orange, grapefruit, or mixed fruit juice
- Only one antihistamine on MAR and home list (fexofenadine vs loratadine, cetirizine, diphenhydramine, etc.)
- Renal function—review basic metabolic panel / creatinine; avoid 180 mg once daily if renal function is decreased
- Aluminum/magnesium antacids—separate from fexofenadine (do not give within 15 minutes per labeling interaction study)
- Hypersensitivity to fexofenadine or formulation excipients
- Pregnancy or breastfeeding—use only if benefit justifies risk per prescribing information
Contraindications
- Known hypersensitivity to fexofenadine or any ingredient in the product (prescribing information)
Rare postmarketing hypersensitivity reactions (including angioedema and anaphylaxis) have been reported in patients who tolerated prior doses—treat as a clinical emergency if systemic signs appear.
Drug interactions
| Agent | Effect | Nursing action |
|---|---|---|
| Fruit juices (grapefruit, orange, apple) | Reduced bioavailability and exposure; wheal/flare suppression smaller with juice than water | Administer with water only; teach patients not to mix with breakfast juice |
| Aluminum/magnesium antacids | Maalox within 15 minutes decreased AUC ~41% and Cmax ~43% in a labeling study | Separate antacid and fexofenadine administration times per pharmacy guidance |
| Erythromycin / ketoconazole | Increased fexofenadine plasma concentrations; no QTc differences vs fexofenadine alone in labeling studies | Flag new macrolide or azole therapy for pharmacist review if toxicity suspected |
| Other antihistamines | Duplicate therapy without added benefit for the same symptoms | Hold duplicate doses; clarify which single agent to continue via medication reconciliation |
On a small screen, swipe or scroll sideways to see the full table.
Administration
- Give with a full glass of water—prescribing information recommends water, not fruit juice
- 180 mg tablets: swallow whole when product labeling directs (do not crush if label restricts)
- ODT products: follow label for empty-stomach timing if specified for that formulation
- Document exact strength, time, liquid vs tablet formulation, and 24-hour total from all sources
Crushing tablets into applesauce or giving with morning orange juice; giving 180 mg once daily when creatinine clearance is reduced; administering with Maalox at the same medication pass; duplicate Allegra plus hospital fexofenadine.
Expected therapeutic response
- Reduced sneezing, rhinorrhea, nasal/ocular itching, and urticaria pruritus—onset within about 1 hour in seasonal allergic rhinitis studies cited in labeling
- Symptom control maintained over the dosing interval when absorption is not blocked by juice or antacids
- If symptoms persist despite correct water administration and dose, prescriber may adjust therapy—do not add a second antihistamine without orders
Red flags — Stop and act
- Anaphylaxis or serious hypersensitivity (angioedema, chest tightness, dyspnea, flushing, systemic rash) — stop drug and treat per emergency pathway
- Allergy symptoms unchanged after several days of labeled dosing with confirmed juice or antacid co-administration — medication may be under-absorbed; notify pharmacist/prescriber
- Dizziness or somnolence after overdose or sedating co-ingestants
- Insomnia, nervousness, or sleep disturbance — rare postmarketing reports per labeling
Adverse effects
Common adverse reactions per prescribing information (≥2% in some adult trials):
| Adverse effect | Nursing notes |
|---|---|
| Headache | Most common in 180 mg once-daily seasonal allergic rhinitis trials (~10% vs 7% placebo) |
| Back pain, stomach discomfort, pain in extremity | Reported at ≥2% in labeling tables—assess for other causes |
| Dizziness | Reported with chronic urticaria dosing; also described with overdose |
| Upper respiratory infection, cough (pediatrics) | May overlap with treated allergic symptoms |
| Vomiting, diarrhea, somnolence/fatigue (young children) | Higher rates in 6 months–5 years studies per labeling |
On a small screen, swipe or scroll sideways to see the full table.
Postmarketing: insomnia, nervousness, sleep disorders, and hypersensitivity reactions (anaphylaxis, urticaria, angioedema, pruritus, rash). Report per facility policy.
Overdose, toxicity, and antidote
Overdose has been reported with dizziness, drowsiness, and dry mouth per prescribing information. Single doses up to 800 mg and higher repeated doses were studied in healthy volunteers without clinically significant adverse events compared with placebo in those trials—clinical toxicity still warrants assessment for co-ingestants.
Antidote
No specific antidote is described in the reviewed prescribing information. Treatment is symptomatic and supportive. Hemodialysis did not effectively remove fexofenadine after terfenadine administration in available data.
Contact local poison control or medical toxicology for intentional overdose, marked CNS depression, or suspected serious toxicity per facility protocol and local emergency guidance.
Look-alike / sound-alike and error prevention
- Fexofenadine vs Allegra-D — D products contain pseudoephedrine; not interchangeable
- 60 mg vs 180 mg tablets — verify strength; 180 mg is once daily and not for decreased renal function
- Fexofenadine vs terfenadine — terfenadine withdrawn; fexofenadine is its active metabolite
- Hospital formulary vs home Allegra bottle — duplicate dosing when both are available
- Sound-alike: faxed/verbal orders for “Allegra” vs “Flexura” or other agents—read back generic name and strength
Practical bedside notes
| Topic | Bedside guidance |
|---|---|
| Breakfast tray | Pass oral meds with water cup—not juice pitcher on the tray |
| Home OTC supply | Allegra is fexofenadine—include bottles in reconciliation |
| Renal trend | Flag rising creatinine—may need 60 mg once daily instead of 180 mg |
| Antacid timing | Separate Maalox-type products from fexofenadine passes |
| Ask pharmacy when | Persistent symptoms despite correct dose, new ketoconazole/erythromycin, or eGFR decline |
On a small screen, swipe or scroll sideways to see the full table.
High-risk populations
| Population | Considerations |
|---|---|
| Older adults (65+) | Peak fexofenadine levels ~99% higher than younger adults in labeling; drug is renally eliminated—use caution in dose selection and monitor renal function |
| Renal impairment | Start 60 mg once daily in adults; avoid 180 mg once daily when renal function is decreased |
| Hepatic impairment | Pharmacokinetics did not differ substantially from healthy subjects in labeling |
| Pediatrics | Tablet dosing from age 6 years per labeling; younger ages use suspension per product-specific label |
| Pregnancy | Use only if potential benefit justifies potential risk—adequate human studies lacking (Pregnancy Category C in labeling) |
| Lactation | Not known if excreted in human milk—use caution; LactMed notes low relative infant dose with usual maternal doses |
| Mild asthma | Does not replace asthma controller therapy |
On a small screen, swipe or scroll sideways to see the full table.
Monitoring and documentation
Monitor
- Allergy symptom relief (rhinitis, urticaria, pruritus) relative to prior dose
- Whether dose was given with water vs juice or near antacids
- Renal function trend when ordered or clinically indicated
- Signs of hypersensitivity after first doses
- Headache, dizziness, or GI complaints
Document
- Dose, strength, time, route, and 24-hour total from all sources
- Fluid used to swallow dose (water vs juice) when relevant to poor response
- Home OTC reconciliation and duplicate-antihistamine counseling
- Renal dose verification when creatinine or eGFR changes
Patient teaching
- Take with water—do not take with apple, orange, or grapefruit juice (FDA consumer guidance lists fexofenadine)
- Do not exceed the prescribed dose; do not combine with other allergy antihistamines unless the prescriber directs
- Separate aluminum/magnesium antacids from this medicine per pharmacist instructions
- Bring all allergy bottles to appointments (Allegra = fexofenadine)
- Seek urgent care for throat swelling, trouble breathing, or widespread rash
- Kidney disease, pregnancy, or breastfeeding—talk with prescriber before starting or changing dose
- Keep tablets and liquid out of reach of children
The Hold Rule
Do not give and contact the prescriber/pharmacist when:
- Known hypersensitivity to fexofenadine or prior serious reaction to the product
- Duplicate antihistamine therapy (MAR + home Allegra + PRN sedating antihistamine)
- Order is 180 mg once daily but patient has decreased renal function without prescriber documentation
- Patient cannot take dose with water (only juice available) and symptoms are uncontrolled—clarify administration plan
- Systemic allergic reaction signs after a dose
- Dose scheduled within 15 minutes of aluminum/magnesium antacid unless pharmacy approves timing
Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.
Clinical practice integration and workflow
Fexofenadine is widely available OTC, so the highest-stakes nursing problems are fruit-juice administration, renal dose selection (60 mg vs 180 mg), antacid timing, and duplicate antihistamine dosing.
1. Check-before-you-give protocol
- Right patient, strength, route, time, and 24-hour total dose
- Water-only administration; document if juice was unavoidable
- One antihistamine for the same symptom set unless prescriber documents otherwise
- Review BMP/creatinine before giving 180 mg once daily
2. High-alert and safety badge
Not a traditional high-alert medication on all lists—treat juice-related absorption failure, renal 180 mg errors, and duplicate OTC dosing as the primary safety story3. Clinical workflow: hold and question rules
- If rhinitis persists and breakfast juice is routine, hold next dose and clarify administration with pharmacy before adding another antihistamine
- If patient took home Allegra plus hospital dose, hold and reconcile—do not add an evening dose automatically
- If systemic allergy signs appear, stop fexofenadine and manage per emergency protocol
4. Critical teach-back questions
- “What should you drink when you take this allergy pill?” (Water—not fruit juice.)
- “Can you take Allegra and another antihistamine together?” (Not unless prescriber approved.)
5. Care coordination
Pharmacist: Renal dose adjustment, antacid spacing, juice interaction counseling, duplicate therapy
Prescriber: Notify for inadequate symptom control at correct administration, hypersensitivity, or need for alternative therapy
🧠 Quick mental checklist
- Will this dose be swallowed with water—not juice?
- Is another antihistamine on the MAR or home list?
- Is eGFR low enough that 180 mg once daily is inappropriate?
- Was an aluminum/magnesium antacid given in the same pass?
- Are allergy symptoms improving after a correctly administered dose?
Fexofenadine NCLEX practice questions
Rehearse NCLEX-style clinical judgment practice for fexofenadine using a tabbed case (MAR, labs, history, nursing notes), then priority action, cue recognition, trend interpretation, matrix urgency sorting, clinical judgment, and documentation cloze—recognise cues → analyse → prioritise → act → evaluate outcomes (fruit-juice absorption, renal dose selection, and duplicate antihistamine safety).
Select a tab to view MAR, labs, history, and nursing note details for this case.
- Fexofenadine 180 mg PO daily — 0800 given with breakfast tray
- Maalox (aluminum/magnesium) 30 mL PO PRN heartburn — 0755 given
- Home med list: OTC Allegra 180 mg (same as fexofenadine)
- Loratadine 10 mg PO daily on MAR — scheduled 2100
- Serum creatinine 1.9 mg/dL (baseline 1.1) → 2.1 mg/dL today
- eGFR 32 mL/min/1.73 m² (was 58 one week ago)
- BMP otherwise stable; potassium 4.0 mmol/L
- 58-year-old with seasonal allergic rhinitis and chronic idiopathic urticaria
- Drinks large glass of orange juice every morning with medications
- History of CKD stage 3—nephrology follow-up
- No prior anaphylaxis to fexofenadine
- 0900: Patient reports “Allegra never works”—took tablet with orange juice and Maalox before breakfast
- 0915: Sneezing and nasal itching unchanged from admission
- 0930: Patient plans to take home Allegra 180 mg tonight in addition to hospital dose
Answer key & rationale
Frequently asked questions
Why must fexofenadine be taken with water and not fruit juice?
Prescribing information states grapefruit, orange, and apple juice may reduce bioavailability; population analysis estimated roughly 36% lower exposure versus water. Take tablets with water to maximize effect.
When should a nurse hold fexofenadine?
Hold for hypersensitivity, duplicate antihistamine therapy, 180 mg once daily with decreased renal function, planned juice administration when symptoms are uncontrolled, or systemic allergic signs.
How is fexofenadine dosed in renal impairment?
Start 60 mg once daily in adults with decreased renal function. The 180 mg once-daily strength is not for patients with decreased renal function per labeling.
What adverse effects matter most?
Headache, back pain, dizziness, and stomach discomfort are common. Postmarketing hypersensitivity including anaphylaxis requires emergency escalation.
Is there an antidote for overdose?
No specific antidote in prescribing information. Supportive care for dizziness, drowsiness, and dry mouth; dialysis was not effective in available data.
What should patients know about pregnancy and breastfeeding?
Use in pregnancy only if benefit justifies risk. Human lactation data are inadequate—use caution in nursing mothers per prescribing information.
References
-
U.S. National Library of Medicine. Fexofenadine hydrochloride tablet — Prescribing information. DailyMed.https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5a207e4-472b-4bf9-8cd3-a018ef3a82bb
-
U.S. Food and Drug Administration. Grapefruit Juice and Some Drugs Don’t Mix. Consumer update.https://www.fda.gov/consumers/consumer-updates/grapefruit-juice-and-some-drugs-dont-mix
-
Drugs and Lactation Database (LactMed). Fexofenadine. Bethesda (MD): National Institute of Child Health and Human Development.https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM111/
Review and transparency
This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.
Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.